Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
$71.81
+1.9%
$75.41
$64.74
$87.77
$6.66B1.31650,685 shs1.70 million shs
Chemed Co. stock logo
CHE
Chemed
$575.24
+0.2%
$617.63
$492.84
$654.62
$8.71B0.4681,905 shs123,044 shs
DaVita Inc. stock logo
DVA
DaVita
$137.52
-0.3%
$134.54
$71.51
$145.04
$12.00B1.04784,901 shs743,486 shs
Globus Medical, Inc. stock logo
GMED
Globus Medical
$64.72
+0.6%
$52.91
$43.38
$65.74
$8.76B1.111.19 million shs1.79 million shs
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
+6.71%+5.63%-7.72%-14.10%+0.95%
Chemed Co. stock logo
CHE
Chemed
+0.34%+2.66%-8.07%-2.58%+4.06%
DaVita Inc. stock logo
DVA
DaVita
+1.55%-3.00%+2.89%+25.56%+38.95%
Globus Medical, Inc. stock logo
GMED
Globus Medical
+4.53%+27.58%+19.97%+22.98%+12.27%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
4.395 of 5 stars
3.34.00.05.02.30.81.3
Chemed Co. stock logo
CHE
Chemed
4.9719 of 5 stars
2.55.03.34.94.02.52.5
DaVita Inc. stock logo
DVA
DaVita
3.7804 of 5 stars
1.23.00.04.52.62.52.5
Globus Medical, Inc. stock logo
GMED
Globus Medical
4.515 of 5 stars
2.31.00.04.13.24.23.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
2.67
Moderate Buy$88.8923.78% Upside
Chemed Co. stock logo
CHE
Chemed
3.00
Buy$681.0018.39% Upside
DaVita Inc. stock logo
DVA
DaVita
2.33
Hold$129.75-5.65% Downside
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.55
Moderate Buy$66.502.75% Upside

Current Analyst Ratings

Latest ACHC, DVA, CHE, and GMED Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/9/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$83.00 ➝ $85.00
5/8/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$55.00 ➝ $60.00
5/8/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$60.00 ➝ $63.00
5/8/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$64.00 ➝ $70.00
5/8/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
5/6/2024
DaVita Inc. stock logo
DVA
DaVita
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$133.00 ➝ $150.00
5/3/2024
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$84.00 ➝ $70.00
5/2/2024
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$105.00 ➝ $90.00
5/2/2024
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$100.00 ➝ $91.00
4/25/2024
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Hold$70.00
3/18/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$60.00
(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
$2.99B2.23$5.32 per share13.51$30.17 per share2.38
Chemed Co. stock logo
CHE
Chemed
$2.26B3.85$25.15 per share22.87$73.55 per share7.82
DaVita Inc. stock logo
DVA
DaVita
$12.14B0.99$16.89 per share8.14$12.91 per share10.65
Globus Medical, Inc. stock logo
GMED
Globus Medical
$1.57B5.59$4.49 per share14.40$29.32 per share2.21

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
-$21.67M-$0.14N/A18.231.96-0.38%11.49%6.07%7/25/2024 (Estimated)
Chemed Co. stock logo
CHE
Chemed
$272.51M$18.5830.9623.992.2912.36%30.52%20.13%7/24/2024 (Estimated)
DaVita Inc. stock logo
DVA
DaVita
$691.53M$8.8015.6313.501.066.61%68.52%4.98%8/1/2024 (Estimated)
Globus Medical, Inc. stock logo
GMED
Globus Medical
$122.87M$1.1755.3219.731.537.83%8.82%7.20%8/1/2024 (Estimated)

Latest ACHC, DVA, CHE, and GMED Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024Q1 2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.55$0.72+$0.17$1.49$586.82 million$606.67 million    
5/2/2024Q1 2024
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
$0.80$0.84+$0.04$0.85$779.20 million$768.10 million    
5/2/2024Q1 24
DaVita Inc. stock logo
DVA
DaVita
$1.95$2.38+$0.43$2.11$3.03 billion$3.07 billion    
4/24/2024Q1 2024
Chemed Co. stock logo
CHE
Chemed
$5.09$4.68-$0.41$5.12$587.18 million$589.23 million    
2/28/2024Q4 2023
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
$0.80$0.85+$0.05$1.07$727.60 million$742.80 million    
2/27/2024Q4 2023
Chemed Co. stock logo
CHE
Chemed
$6.25$6.60+$0.35$7.30$586.64 million$585.90 million    
2/20/2024Q4 2023
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.59$0.60+$0.01$1.09$608.21 million$616.53 million    
2/13/2024Q4 23
DaVita Inc. stock logo
DVA
DaVita
$1.53$1.87+$0.34$2.12$3.01 billion$3.15 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
N/AN/AN/AN/AN/A
Chemed Co. stock logo
CHE
Chemed
$1.600.28%+5.73%8.61%15 Years
DaVita Inc. stock logo
DVA
DaVita
N/AN/AN/AN/AN/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A

Latest ACHC, DVA, CHE, and GMED Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/16/2024
Chemed Co. stock logo
CHE
Chemed
quarterly$0.400.27%2/23/20242/26/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
0.63
1.27
1.27
Chemed Co. stock logo
CHE
Chemed
N/A
1.91
1.88
DaVita Inc. stock logo
DVA
DaVita
7.95
1.43
1.37
Globus Medical, Inc. stock logo
GMED
Globus Medical
0.10
4.88
2.72

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
N/A
Chemed Co. stock logo
CHE
Chemed
95.85%
DaVita Inc. stock logo
DVA
DaVita
90.12%
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%

Insider Ownership

CompanyInsider Ownership
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
2.00%
Chemed Co. stock logo
CHE
Chemed
3.32%
DaVita Inc. stock logo
DVA
DaVita
1.40%
Globus Medical, Inc. stock logo
GMED
Globus Medical
24.30%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
23,50092.78 million90.92 millionOptionable
Chemed Co. stock logo
CHE
Chemed
15,08715.14 million14.64 millionOptionable
DaVita Inc. stock logo
DVA
DaVita
70,00087.70 million86.47 millionOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
5,000135.37 million102.48 millionOptionable

ACHC, DVA, CHE, and GMED Headlines

SourceHeadline
David D. Davidar Sells 20,000 Shares of Globus Medical, Inc. (NYSE:GMED) StockDavid D. Davidar Sells 20,000 Shares of Globus Medical, Inc. (NYSE:GMED) Stock
marketbeat.com - May 10 at 6:44 PM
Roth Capital Research Analysts Lower Earnings Estimates for Globus Medical, Inc. (NYSE:GMED)Roth Capital Research Analysts Lower Earnings Estimates for Globus Medical, Inc. (NYSE:GMED)
marketbeat.com - May 10 at 10:21 AM
Globus Medical (NYSE:GMED) PT Raised to $63.00 at BTIG ResearchGlobus Medical (NYSE:GMED) PT Raised to $63.00 at BTIG Research
americanbankingnews.com - May 10 at 6:26 AM
Globus Medical, Inc. (NYSE:GMED) Expected to Post FY2026 Earnings of $3.77 Per ShareGlobus Medical, Inc. (NYSE:GMED) Expected to Post FY2026 Earnings of $3.77 Per Share
americanbankingnews.com - May 10 at 4:48 AM
Globus Medical (NYSE:GMED) Stock Rating Reaffirmed by Needham & Company LLCGlobus Medical (NYSE:GMED) Stock Rating Reaffirmed by Needham & Company LLC
americanbankingnews.com - May 10 at 2:50 AM
Analysts Issue Forecasts for Globus Medical, Inc.s Q2 2024 Earnings (NYSE:GMED)Analysts Issue Forecasts for Globus Medical, Inc.'s Q2 2024 Earnings (NYSE:GMED)
americanbankingnews.com - May 10 at 2:16 AM
Globus Medical Reports Strong Sales Growth Post-NuVasive Merger Despite Quarterly Net LossGlobus Medical Reports Strong Sales Growth Post-NuVasive Merger Despite Quarterly Net Loss
msn.com - May 10 at 1:26 AM
Global Partners LP (NYSE:GLP) Q1 2024 Earnings Call TranscriptGlobal Partners LP (NYSE:GLP) Q1 2024 Earnings Call Transcript
msn.com - May 9 at 3:25 PM
Key Takeaways From Globus Medical Analyst RatingsKey Takeaways From Globus Medical Analyst Ratings
benzinga.com - May 9 at 3:25 PM
Globus Medical (NYSE:GMED) PT Raised to $85.00Globus Medical (NYSE:GMED) PT Raised to $85.00
marketbeat.com - May 9 at 1:10 PM
GMED or PEN: Which Is the Better Value Stock Right Now?GMED or PEN: Which Is the Better Value Stock Right Now?
zacks.com - May 9 at 12:41 PM
Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue?Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue?
zacks.com - May 9 at 10:16 AM
Globus Medical, Inc. (NYSE:GMED) to Post FY2026 Earnings of $3.77 Per Share, Zacks Research ForecastsGlobus Medical, Inc. (NYSE:GMED) to Post FY2026 Earnings of $3.77 Per Share, Zacks Research Forecasts
marketbeat.com - May 9 at 8:23 AM
Natixis Advisors L.P. Acquires 47,047 Shares of Globus Medical, Inc. (NYSE:GMED)Natixis Advisors L.P. Acquires 47,047 Shares of Globus Medical, Inc. (NYSE:GMED)
marketbeat.com - May 9 at 6:01 AM
FY2025 EPS Estimates for Globus Medical, Inc. Increased by Zacks Research (NYSE:GMED)FY2025 EPS Estimates for Globus Medical, Inc. Increased by Zacks Research (NYSE:GMED)
americanbankingnews.com - May 9 at 3:04 AM
Three Growth Companies With High Insider Ownership And 36% Earnings GrowthThree Growth Companies With High Insider Ownership And 36% Earnings Growth
finance.yahoo.com - May 9 at 2:38 AM
Globus Medical (NYSE:GMED) Hits New 1-Year High on Better-Than-Expected EarningsGlobus Medical (NYSE:GMED) Hits New 1-Year High on Better-Than-Expected Earnings
americanbankingnews.com - May 9 at 1:42 AM
Globus Medical Shares Rise 22% on Raised FY Outlook, 1Q Revenue BeatGlobus Medical Shares Rise 22% on Raised FY Outlook, 1Q Revenue Beat
marketwatch.com - May 8 at 4:37 PM
Strong Buy: Globus Medical’s Robust Performance and Strategic Growth OutlookStrong Buy: Globus Medical’s Robust Performance and Strategic Growth Outlook
markets.businessinsider.com - May 8 at 4:37 PM
Globus Medical Up 23% As Q1 Results Beat Street; Raises FY OutlookGlobus Medical Up 23% As Q1 Results Beat Street; Raises FY Outlook
markets.businessinsider.com - May 8 at 4:37 PM
Globus Medical Shares Race Higher After Better-Than-Expected Q1 ResultsGlobus Medical Shares Race Higher After Better-Than-Expected Q1 Results
msn.com - May 8 at 4:37 PM
Globus Medical, Inc. (NYSE:GMED) Q1 2024 Earnings Call TranscriptGlobus Medical, Inc. (NYSE:GMED) Q1 2024 Earnings Call Transcript
finance.yahoo.com - May 8 at 4:37 PM
Globus Medical (NYSE:GMED) Releases  Earnings Results, Beats Estimates By $0.17 EPSGlobus Medical (NYSE:GMED) Releases Earnings Results, Beats Estimates By $0.17 EPS
marketbeat.com - May 8 at 2:08 PM
Piper Sandler Increases Globus Medical (NYSE:GMED) Price Target to $60.00Piper Sandler Increases Globus Medical (NYSE:GMED) Price Target to $60.00
marketbeat.com - May 8 at 1:09 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Acadia Healthcare logo

Acadia Healthcare

NASDAQ:ACHC
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Chemed logo

Chemed

NYSE:CHE
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
DaVita logo

DaVita

NYSE:DVA
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Globus Medical logo

Globus Medical

NYSE:GMED
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.